XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 27.32

-4.7%

11:32 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (10207)	5/27/1999 12:26:00 AM
From: aknahow	Read Replies (3) of 17367

Murphy was restrained, and thinks until at least 40 days and unblinding at what will then be the 69 day look back we will not know if the neuprex is significantly efficacious. Depends on the mortality rate for meningococcemia. If it is only 15% then the stats will not look so good. Seems he ignores the fact that the trial involved Glasgow 12-15 as well as 8-11.My theory. In addition he said that 4 of the 62 who died but were not yet enrolled in the trials got the drug. I will try to clarify this with the company as it is difficult to see how one gets the drug being investigated if not enrolled. Murphy is pissed because when XOMA was pissed at him they told him there would be no surprise at the annual meeting, and he repeated this to his customers. He did not mention the pending deals. A bit strange since he normally would make a big deal about this. Also here is a person that has gone from talking about zero deaths to his present position.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next